Concepts (97)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Developing Countries | 5 | 2023 | 2674 | 1.840 |
Why?
|
| Authorship | 2 | 2022 | 266 | 1.450 |
Why?
|
| Breast Neoplasms | 9 | 2022 | 19800 | 0.970 |
Why?
|
| Pathology, Molecular | 2 | 2022 | 347 | 0.900 |
Why?
|
| Health Facilities | 2 | 2022 | 450 | 0.820 |
Why?
|
| Haiti | 4 | 2022 | 544 | 0.740 |
Why?
|
| Publications | 1 | 2022 | 205 | 0.730 |
Why?
|
| Chemotherapy, Adjuvant | 3 | 2022 | 3515 | 0.680 |
Why?
|
| Neoplasms | 9 | 2023 | 20172 | 0.610 |
Why?
|
| Health Services Accessibility | 4 | 2022 | 4988 | 0.590 |
Why?
|
| Nuts | 1 | 2018 | 236 | 0.590 |
Why?
|
| Rwanda | 7 | 2022 | 746 | 0.550 |
Why?
|
| Workload | 1 | 2018 | 852 | 0.440 |
Why?
|
| Medical Oncology | 5 | 2022 | 2098 | 0.420 |
Why?
|
| Caribbean Region | 2 | 2020 | 175 | 0.400 |
Why?
|
| Neoplasm Recurrence, Local | 3 | 2020 | 8877 | 0.290 |
Why?
|
| Colonic Neoplasms | 1 | 2018 | 2535 | 0.290 |
Why?
|
| Income | 2 | 2021 | 1775 | 0.230 |
Why?
|
| Delivery of Health Care | 5 | 2021 | 4810 | 0.220 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 3 | 2020 | 11253 | 0.210 |
Why?
|
| Technology | 1 | 2022 | 237 | 0.200 |
Why?
|
| Oncology Service, Hospital | 1 | 2020 | 59 | 0.200 |
Why?
|
| Ethiopia | 1 | 2022 | 463 | 0.200 |
Why?
|
| Medical Tourism | 1 | 2020 | 54 | 0.190 |
Why?
|
| Diet | 1 | 2018 | 7392 | 0.190 |
Why?
|
| Review Literature as Topic | 1 | 2021 | 316 | 0.190 |
Why?
|
| Africa South of the Sahara | 1 | 2022 | 685 | 0.190 |
Why?
|
| Cost-Benefit Analysis | 2 | 2021 | 5235 | 0.170 |
Why?
|
| Humans | 26 | 2023 | 708843 | 0.170 |
Why?
|
| Retrospective Studies | 7 | 2022 | 71483 | 0.160 |
Why?
|
| HIV Infections | 1 | 2022 | 15538 | 0.150 |
Why?
|
| Poverty | 2 | 2021 | 2557 | 0.150 |
Why?
|
| Diet Records | 1 | 2018 | 419 | 0.150 |
Why?
|
| Travel | 1 | 2022 | 726 | 0.150 |
Why?
|
| Pregnancy Complications, Neoplastic | 1 | 2018 | 265 | 0.150 |
Why?
|
| Estrogens | 1 | 2022 | 1511 | 0.140 |
Why?
|
| Nutritive Value | 1 | 2018 | 335 | 0.140 |
Why?
|
| Epstein-Barr Virus Infections | 1 | 2020 | 534 | 0.130 |
Why?
|
| Female | 11 | 2022 | 375205 | 0.130 |
Why?
|
| Mastectomy | 1 | 2022 | 1680 | 0.120 |
Why?
|
| Breast | 1 | 2022 | 1782 | 0.120 |
Why?
|
| Cross-Sectional Studies | 3 | 2022 | 23020 | 0.120 |
Why?
|
| Hodgkin Disease | 1 | 2020 | 1412 | 0.110 |
Why?
|
| Patient Education as Topic | 1 | 2023 | 2340 | 0.110 |
Why?
|
| Rural Population | 1 | 2022 | 2130 | 0.110 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2018 | 1454 | 0.100 |
Why?
|
| Disease-Free Survival | 1 | 2020 | 7026 | 0.090 |
Why?
|
| Immunohistochemistry | 1 | 2022 | 11790 | 0.090 |
Why?
|
| RNA, Messenger | 1 | 2022 | 13314 | 0.080 |
Why?
|
| Health Policy | 1 | 2018 | 2615 | 0.070 |
Why?
|
| Prospective Studies | 2 | 2020 | 50597 | 0.070 |
Why?
|
| Pandemics | 2 | 2021 | 7089 | 0.060 |
Why?
|
| Neoplasm Staging | 1 | 2018 | 11126 | 0.060 |
Why?
|
| Body Mass Index | 1 | 2020 | 12366 | 0.060 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3153 | 0.060 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3275 | 0.050 |
Why?
|
| Healthcare Disparities | 1 | 2017 | 2996 | 0.050 |
Why?
|
| Health Resources | 2 | 2020 | 922 | 0.050 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2018 | 9488 | 0.050 |
Why?
|
| Africa, Eastern | 1 | 2020 | 71 | 0.050 |
Why?
|
| Colorectal Neoplasms | 1 | 2020 | 6497 | 0.050 |
Why?
|
| Incidence | 1 | 2018 | 20320 | 0.050 |
Why?
|
| Prognosis | 1 | 2020 | 28919 | 0.050 |
Why?
|
| Bleomycin | 1 | 2020 | 503 | 0.050 |
Why?
|
| Africa | 1 | 2021 | 656 | 0.050 |
Why?
|
| Policy | 1 | 2022 | 359 | 0.040 |
Why?
|
| Vinblastine | 1 | 2020 | 505 | 0.040 |
Why?
|
| Hospitals, District | 1 | 2018 | 97 | 0.040 |
Why?
|
| Dacarbazine | 1 | 2020 | 585 | 0.040 |
Why?
|
| World Health Organization | 1 | 2022 | 1261 | 0.040 |
Why?
|
| Cancer Care Facilities | 1 | 2018 | 414 | 0.040 |
Why?
|
| Time Factors | 1 | 2018 | 41038 | 0.040 |
Why?
|
| Delayed Diagnosis | 1 | 2018 | 409 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2018 | 61932 | 0.030 |
Why?
|
| Herpesvirus 4, Human | 1 | 2020 | 1241 | 0.030 |
Why?
|
| Papillomaviridae | 1 | 2020 | 1124 | 0.030 |
Why?
|
| Doxorubicin | 1 | 2020 | 2235 | 0.030 |
Why?
|
| Male | 2 | 2022 | 349524 | 0.030 |
Why?
|
| Risk Factors | 1 | 2018 | 69553 | 0.030 |
Why?
|
| Consensus | 1 | 2020 | 2713 | 0.030 |
Why?
|
| Needs Assessment | 1 | 2017 | 1147 | 0.020 |
Why?
|
| Health Promotion | 1 | 2022 | 2172 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2022 | 8896 | 0.020 |
Why?
|
| Health Services Needs and Demand | 1 | 2017 | 1435 | 0.020 |
Why?
|
| Forecasting | 1 | 2017 | 2941 | 0.020 |
Why?
|
| Middle Aged | 2 | 2018 | 213752 | 0.020 |
Why?
|
| Communication | 1 | 2020 | 3455 | 0.020 |
Why?
|
| Decision Making | 1 | 2020 | 3802 | 0.020 |
Why?
|
| Aged | 1 | 2018 | 161488 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2018 | 10507 | 0.020 |
Why?
|
| Adolescent | 2 | 2020 | 84718 | 0.010 |
Why?
|
| Early Detection of Cancer | 1 | 2014 | 2865 | 0.010 |
Why?
|
| Pregnancy | 1 | 2018 | 26832 | 0.010 |
Why?
|
| Adult | 2 | 2018 | 211041 | 0.010 |
Why?
|
| United States | 1 | 2020 | 67165 | 0.010 |
Why?
|
| Young Adult | 1 | 2018 | 55940 | 0.010 |
Why?
|
| Child | 1 | 2018 | 73636 | 0.010 |
Why?
|
Concepts
(97)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(28)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_